Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
McKinsey
Federal Trade Commission
Novartis
Farmers Insurance
Cerilliant
AstraZeneca
Accenture
QuintilesIMS
Johnson and Johnson

Generated: October 22, 2017

DrugPatentWatch Database Preview

Methoxsalen - Generic Drug Details

« Back to Dashboard

What are the generic sources for methoxsalen and what is the scope of methoxsalen freedom to operate?

Methoxsalen
is the generic ingredient in five branded drugs marketed by Dow Pharm, Actavis Inc, Valeant Pharm Intl, Mallinckrodt Hosp, Idt Australia Ltd, and Strides Pharma, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for methoxsalen. Five suppliers are listed for this compound.

Summary for Generic Name: methoxsalen

US Patents:0
Tradenames:5
Applicants:6
NDAs:6
Drug Master File Entries: see list7
Suppliers / Packagers: see list5
Bulk Api Vendors: see list82
Clinical Trials: see list16
Patent Applications: see list4,970
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:methoxsalen at DailyMed

Pharmacology for Ingredient: methoxsalen

Ingredient-typePsoralens
Drug ClassPhotoactivated Radical Generator
Psoralen
Mechanism of ActionPhotoabsorption
Physiological EffectPhotosensitizing Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt Hosp
UVADEX
methoxsalen
INJECTABLE;INJECTION020969-001Feb 25, 1999RXYesYes► Subscribe► Subscribe► Subscribe
Actavis Inc
METHOXSALEN
methoxsalen
CAPSULE;ORAL202603-001Jun 9, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Idt Australia Ltd
METHOXSALEN
methoxsalen
CAPSULE;ORAL087781-001Jun 8, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant Pharm Intl
8-MOP
methoxsalen
CAPSULE;ORAL009048-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Dow Pharm
OXSORALEN-ULTRA
methoxsalen
CAPSULE;ORAL019600-001Oct 30, 1986ABRXYesYes► Subscribe► Subscribe► Subscribe
Strides Pharma
METHOXSALEN
methoxsalen
CAPSULE;ORAL202687-001Jun 5, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Valeant Pharm Intl
OXSORALEN
methoxsalen
LOTION;TOPICAL009048-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: methoxsalen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dow Pharm
OXSORALEN-ULTRA
methoxsalen
CAPSULE;ORAL019600-001Oct 30, 1986► Subscribe► Subscribe
Mallinckrodt Hosp
UVADEX
methoxsalen
INJECTABLE;INJECTION020969-001Feb 25, 1999► Subscribe► Subscribe
Mallinckrodt Hosp
UVADEX
methoxsalen
INJECTABLE;INJECTION020969-001Feb 25, 1999► Subscribe► Subscribe
Mallinckrodt Hosp
UVADEX
methoxsalen
INJECTABLE;INJECTION020969-001Feb 25, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Teva
Cantor Fitzgerald
Novartis
Express Scripts
Argus Health
QuintilesIMS
US Department of Justice
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot